Member Info for VanVan

Many thanks Ali.

I see in the past the Co. paid Special Dividends, as non strategic assets were sold off and funds subsequently returned to shareholders.,

Do we now expect going forward, that surplus cash will be used for "Buy Backs" (not dividends) to pay down any remaining debt (strengthen Balance Sheet) and perhaps for a North Sea or other acquisition? Has the Co. since Randy took the helm, talked about a future Dividend strategy, because I can't find anything?

Finally, can I ask, is this potential takeover genuine or just noise, which will be batted away? It seems that the Market doesn't take it very seriously as any expected SP movement on the back of this approach has been muted. Do you agree? Not long to find out (8th April).

I guess, for whatever reason Capricorn remains a very under the radar stock which keeps it away from wide fluctuations. Probably a good thing.

Who is the "we" in the article please? What is the source? Thank you

On Linkedln :-

This week, Kerim Sener, Chairman of AAU, visited Xinhai HQ. Discussions focused on Dokwe, and how EPC+M+0 capabilities can accelerate project development.

Dokwe: one of Zimbabwe’s largest undeveloped gold assets.

12kmmineralised strike, 1.1 m ozs

JORC resource Only 10% explored

Development plan: 2.5Mt/a CIL plant

Target: 3t gold per year

In December 2025, Xinhai invested AUD 11m and became the largest shareholder of Ariana Resources.

The best partnerships bring together great assets and real capabilities. That's what we're building here.

Stay tuned.

Ariana Resources plc

More about Xinhai: hxxps://lnkd.in/gk6fPvHP

#XinhaiMining #DokweGold

#ArianaResources

#Zimbabwe

Also 4 pictures

All these things are being covered in the current Investor Meet Co. Presentation. Still live. Not yet reached the Q&A session. A recording will be available for those who can’t listen live.

Very positive stuff. Outlook looks great imo

Scancell will be at the AACR Annual Meeting 2026 in San Diego, from April 17-22, and will have a poster presentation.

Title: SCOPE, A phase 2 clinical trial with off-the-shelf DNA plasmid vaccine in first line advanced melanoma combined with check point blockade, shows good T cell responses which correlate with long progression free survival

Session Title: Phase II Clinical Trials, April 21 from 2-5pm ET

Location: Poster Section 50, Poster Board Number 2

Abstract Presentation Number: CT237

We’re looking forward to seeing you there.

#Conference #Investing #Biotech #Healthcare #Cancer #Oncology

 

Scancell will be at the NextGen Biomed by Oxford Global conference, in London March 23-25th.

Callum Scott, SVP of Development will be giving an industry presentation on on Developing Potency Assays for Cancer Vaccines: Navigating Technical, Regulatory & Commercial Challenges and a roundtable discussion on Cancer Vaccine Strategies In 2026 & Beyond – Regulatory Considerations & Future Outlook.

RR sounded quite positive in the House on Rosebank & Jackdaw. Said the Oil CO’s had to resubmit their applications to Courts but said they will honour any licences already agreed if Courts give go ahead . But could still be delayed until Autumn

RR sounded quite positive on Rosebank & Jackdaw. Said the Oil CO’s had to resubmit their applications to Courts at end of 2025, but said they will honour any licences already agreed if Courts give go ahead . But could still be delayed until Autumn

Reported on GB News this morning:-

Ed Miliband’s "cult-like fanaticism" over net zero is "making Britain weaker and poorer", the Conservatives have claimed.

Tory leader Kemi Badenoch is set to use an opposition day in Parliament on Tuesday to force a vote on unlocking development of the Rosebank oil field and the Jackdaw gas field in the North Sea.

Reported on GB News this morning:-

Ed Miliband’s "cult-like fanaticism" over net zero is "making Britain weaker and poorer", the Conservatives have claimed.

Tory leader Kemi Badenoch is set to use an opposition day in Parliament on Tuesday to force a vote on unlocking development of the Rosebank oil field and the Jackdaw gas field in the North Sea.

On Linkedln

Our CFO Sath Nirmalananthan presented Scancell's latest progress at the Oppenheimer 36th Annual Healthcare Life Sciences Conference.

Sath looks at the significant progress we've made with lead asset iSCIB1+ and plans to progress into Phase 3 – and you can see the recording of the presentation here.

https://lnkd.in/eZqUjqgT

#Biotech #Cancer #Oncology #ImmunoBody #ClinicalDevelopment

The events of recent days underline the importance of maximising our domestic oil and gas resources...here is how we could do it

A regulatory reset to unlock exploration and production with a focus on fast delivery:

1. Rename the NTSA as the Oil & Gas Authority

with a mandate to maximise economic recovery

- Scrap the net zero obligation and offshore

electrification requirements

- Create a one-stop consenting model created

with hard statutory timelines and parallel

decision-making

2. Prioritise fast delivery of new production.

- Licencing processes should aim to turn

acreage into wells as soon as possible

- Hold regular licencing rounds and enforce-

ment of Use-It-Or-Lose-It principles (with

time relief where third-party access issues

cause delays)

- Tie-backs and simple Exploration &

Appraisal (E&A) wells fast-tracked with

bespoke reviews only required if sensitive

receptors are triggered

- Tie-backs should be treated as extensions

to existing projects and not new projects,

with minimal incremental checks

3. Streamline and standardise environmental

regulation

- Focus on punishing actual harm, rather than

restricting routine operations

- This means strict penalties for actual harm

including spills and blow-outs to incentivise

responsible development, avoiding the need

for complex, detailed pre-permit analysis

- Revert to pre-net zero guidance on flaring

and venting where operators could only

flare/vent with consent, based on operational

necessity, with reporting and penalties for

breaches

4. Maximise production from existing fields

- Cessation of Production (CoP) should be

deferred where possible

- OSPAR derogations used to streamline

decommissioning and minimise cost

- Defer Plug & Abandon (P&A) where near

field tie-backs are credible

- Develop a Supportive fiscal regime to

maximise production

- Abolish the Energy Profits Levy (EPL)

- Create tax incentives to stimulate

production growth through new exploration

and appraisal, and extending field life/

delaying decommissioning

The EPL flatters the books in the short term but it discourages the new projects that would keep revenues flowing, while locking in tens of billions of decommissioning relief claims in the early 2030s — just outside the OBR horizon

If the EPL is not abolished, the middle years of the next Parliament will see these claims fall due, leading to £billions in cash outflows from the Treasury

Tax incentives could include:

▪️cash refunds for ring fenced loses from

seismic and E&A wells (capped per period,

with claw back on development to

deter churn)

▪️super-deduction for the first commercial

discovery eg 130% uplift on qualifying

exploration leading to approved (Field

Development Plan) FDP in 5 years

▪️full expensing in-year for tie-back

Expecting positive news for North Sea Oil & Gas industry perhaps from Rachael from Accounts in Spring Statement on 3rd.

Plus spike in

Oil & gas prices due to Iran war. Straits of Hormuz closed ?

On Linkedln:-

Looking forward to participating once again at the Prospectors & Developers Association of Canada (PDAC) Convention in Toronto from March 1–4.

PDAC remains the most important global platform for the mining and exploration industry — bringing together investors, operators, governments, and technical experts at a time when critical raw materials are central to the energy transition and economic security.

This year, in addition to presenting our ongoing projects with our current partners (Newmont Corporation, Ariana Resources plc and Avrupa Minerals Ltd.), discussing mining governance, regulatory certainty, and responsible development, I will also be introducing the early concept of a new initiative focused specifically on Critical Raw Materials (CRM) exploration and development.

The vision is clear:

-Advance strategic exploration of energy and technology metals

-Align with EU and global CRM priorities

Strengthen responsible mining governance and ESG integration from day one

-Build long-term partnerships with strategic investors

As global demand for critical minerals accelerates, emerging jurisdictions must position themselves not only geologically, but institutionally and strategically.

I look forward to constructive meetings, serious investor dialogue, and taking the first steps toward what I believe will be an important new chapter in responsible CRM development.

Contact:

+383 45 402020

mentordemi@gmail.com

Was there any feedback from the Oppenheimer 36th Arm Healthcare Life Science Conference 25th - 27th please?

This is the question I asked of Phil on Linkedln out of interest.

What happened today? Did you hold back a bit?

Phil replied to me on Linkedln after I asked why he had held back yesterday.

Hello J… in this setting I don’t want to give too much away about why mechanistically we believe we are seeing such good results in terms of T cell biology and clinical benefit. I want to now build new vaccines with immunobody.

Phil L’Huillier tomorrow Lumanity panel . Have you registered to listen in?

Https://youtu.be/vttNhpx-eQQ?si=XKid_lh6jHkm3Qd4

Why are we so excited about the Phase 2 iSCIB1+ data?

Well, one reason is because the progression free survival curve for iSCIB1+ in advanced melanoma is flat – find out why that’s so important in this clip from CEO Phil L'Huillier in our latest financials call.

https://lnkd.in/euFseUJx

#ImmunoBody #Cancer #Oncology #ClinicalDevelopment #Milestones #Melanoma #Biotech #CancerFree